BSECompany Update4 Nov 2026 · 4 Nov 2026, 11:39 am
Pls find enclosed Earnings Call Written Transcript
Ajanta Pharma Ltd · 532331
✦ AI SummaryResults
Ajanta Pharma Ltd has uploaded the written transcript of its earnings call held on 30th October 2026 on its website, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Attachments (1)
📄pdf
Download →
99c75e17-824f-4e07-b44d-682ee9ccac73.pdf
View document text
Ajanta Pharma Limited
Ajanta Tower, 54-A, M Vasanji T +91 22 6060 9000
Road, Chakala, Andheri (E), E legal.info@ajantapharma.com
Mumbai 400 093, India W www.ajantapharma.com
4th November 2026
BSE LIMITED National Stock Exchange of India,
Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot no.
Dalal Street, C/1, G Block, Bandra Kurla Complex,
Mumbai – 400001 Bandra (East), Mumbai – 400 051
Scrip Code: BSE – AJANTPHARM 532331 Scrip Code: NSE AJANTPHARM EQ
Sub: Written transcript of Earnings call conducted on 30th October 2026
Dear Sir / Madam,
Further to our communication dated 30th October 2026 on earnings call, pursuant to
Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015,
written transcript of the earnings call held on 30th October 2026 at 4.00 p.m. has been
uploaded on the Company’s website and can be accessed through the link
https://www.ajantapharma.com/assets/frontend/images/investors/files/quarterly_results
/1793770716_Earnings-Call-Transcript-Q2-%28Jul-Sep%29-2026-27.pdf
This is for your information and records please.
Yours faithfully,
GAURANG SHAH
Sr. VP – Legal & Company Secretary
Corporate Identity Number - L24230MH1979PLC022059